Multidrug-resistant tuberculosis: When to suspect multidrug-resistant TB in adolescents
DOI:
https://doi.org/10.56294/piii2023150Keywords:
multidrug-resistant tuberculosis, extensively drug-resistant tuberculosis, Adolescents, diagnostic, antituberculosis drugsAbstract
Background: (the etiological agent mycobacterium tuberculosis, which causes the disease Tuberculosis, annually causes about 3 million deaths and latently infects between one and 2 million people. it is estimated that 4% of the cases correspond to multidrug- resistant and extensively resistant Mycobacterium tuberculosis. Both classifications constitute a worldwide public healt problem. Their early detection would reduce the burden of the disease and the speed of treatment modification. Material and methods: A systematic review of virtual bibliographic databases was made based on evidence presented in scientific articles, reviews an meta- analyses. The databases uses were: Pubmed, Epistemonikos, Google scholar, Open Athens, Tripdatabase, Cocrcane and Scielo.Results:9 studies were selected for review and found several risk factors associated with MDR-TB in adolescents and adults, such as body mass index less than 18.5, HIV/AIDS, alcohol and drug- related substance use. Conclusion: Education In both adolescents and adults should be a key point to prevent MDR-TB with biomolecular testing Is necessary for timely and appropiate trearment
References
Alvis-Zakzuk NJ, Carrasquilla MD los Á, Gómez VJ, primario (tal como la validez de una investigación) se vea influenciado por un interés secundario (tal como una ganancia económica). Debe declararse la transparencia de la investigación.
Robledo J, Alvis -Guzmán NR, Hernández JM. Diagnostic accuracy of three technologies for the diagnosis of multi-drug resistant tuberculosis. Biomédica. 1 de septiembre de 2017;37(3):397. DOI: https://doi.org/10.7705/biomedica.v37i3.3437
González DRC, Suárez DGA, Roberto D, Peña M, Vargas R. Comportamiento de la tuberculosis en adolescentes de 15 a 18 años. Rev Cuba Pediatría.:9.
Zabaleta A, Llerena C. Serie de casos: tuberculosis extremadamente resistente a drogas en Colombia, 2006-2016. Biomédica. 1 de diciembre de 2019;39(4):707-14. DOI: https://doi.org/10.7705/biomedica.4842
Snow KJ, Nelson LJ, Sismanidis C, Sawyer SM, Graham SM. Incidence and prevalence of bacteriologically confirmed pulmonary tuberculosis among adolescents and young adults: a systematic review. Epidemiol Infect. junio de 2018;146(8):946-53. DOI: https://doi.org/10.1017/S0950268818000821
Snow KJ, Cruz AT, Seddon JA, Ferrand RA, Chiang SS, Hughes JA, et al. Adolescent tuberculosis. Lancet Child Adolesc Health. enero de 2020;4(1):68-79. DOI: https://doi.org/10.1016/S2352-4642(19)30337-2
Beltrame LS. enfermedades infecciosas | tuberculosis. :70.
Feng Y, Liu S, Wang Q, Wang L, Tang S, Wang J, et al. Rapid Diagnosis of Drug Resistance to Fluoroquinolones, Amikacin, Capreomycin, Kanamycin and Ethambutol Using Genotype MTBDRsl Assay: A Meta-Analysis. Mokrousov I, editor. PLoS ONE. 1 de febrero de 2013;8(2):e55292. DOI: https://doi.org/10.1371/journal.pone.0055292
Palmero DJ, Lagrutta L, Inwentarz SJ, Vescovo M, Aidar OJ, Montaner PJG. TRATAMIENTO DE LA TUBERCULOSIS DROGORRESISTENTE EN ADULTOS Y NIÑOS. REVISIÓN NARRATIVA. 2022;13.
Palmero DJ, Laniado Laborín R, Caminero Luna JA. Guías latinoamericanas de diagnóstico y tratamiento de la tuberculosis farmacorresistente. Arch Bronconeumol. octubre de 2008;44(10):578. DOI: https://doi.org/10.1157/13126840
Vigo A, Solari L, Santos D, Puyén ZM. Mutaciones que confieren resistencia a fármacos antituberculosis de primera línea en Perú: una revisión sistemática de la literatura. Rev Peru Med Exp Salud Pública. 6 de diciembre de 2019;36(4):636-45. DOI: https://doi.org/10.17843/rpmesp.2019.364.4722
Kaur R, Kachroo K, Sharma J, Vatturi S, Dang A. Diagnostic accuracy of xpert test in tuberculosis detection: A systematic review and metaanalysis. J Glob Infect Dis. 2016;8(1):32. DOI: https://doi.org/10.4103/0974-777X.176143
Pillay S, Davies GR, Chaplin M, De Vos M, Schumacher SG, Warren R, et al. Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin. Cochrane Infectious Diseases Group, editor. Cochrane Database Syst Rev [Internet]. 29 de junio de 2021 [citado 5 de octubre de 2022];2021(6). Disponible en: http://doi.wiley.com/10.1002/14651858.CD014 DOI: https://doi.org/10.1002/14651858.CD014841
Espinoza KGC, Romero VVC. TUBERCULOSIS EXTREMADAMENTE DROGORRESISTENTE (XDR): UNA AMENAZA PERMANENTE.;(1):6.
Reta MA, Tamene BA, Abate BB, Mensah E, Maningi NE, Fourie PB. Mycobacterium tuberculosis Drug Resistance in Ethiopia: An Updated Systematic Review and Meta-Analysis. Trop Med Infect Dis. 14 de octubre de 2022;7(10):300. DOI: https://doi.org/10.3390/tropicalmed7100300
Kajogoo VD, Lalashowi J, Olomi W, Atim MG, Assefa DG, Sabi I. Treatment outcomes of multidrug resistant tuberculosis patients with or without human immunodeficiency virus coinfection in Africa and Asia: Systematic review and meta-analysis. Ann Med Surg. junio de 2022;78:103753. DOI: https://doi.org/10.1016/j.amsu.2022.103753
Ruano DS, Palermo D, Ritacco V, Ambroggi M, Cusmano L, Romano M, et al. Brote de tuberculosis multirresistente en trabajadores sexuales travestidas. Buenos Aires Argentina. 2005;7.
Wagnew F, Alene KA, Kelly M, Gray D. The effect of undernutrition on sputum culture conversion and treatment outcomes among people with multidrug-resistant tuberculosis: A systematic review and meta-analysis. Int J Infect Dis. diciembre de 2022;S120197122200635X.
Saturno D, Eblen A. TUBERCULOSIS REEMERGING DISEASES. MULTIDRUG RESISTANT. A REPORT CASE. :4.
Manuel ÁG, Fernando D la V, Ariel BE, Merle LH, Diana NT, Cherina HB. TUBERCULOSIS RESISTENTE A MÚLTIPLES MEDICAMENTOS.;6.
Chávez Salazar MR, Valenzuela Ortega VK, López Contreras FO, Moran Vergara L, Robles Urgilez A. Tuberculosis Multirresistente (MDR TB): evolución de un caso resistente a Rifampicina. J Am Health. 4 de julio de 2020;3(3):13-7. DOI: https://doi.org/10.37958/jah.v3i3.55
Han YR, Wang TH, Gong WP, Liang JQ, An HR. Clinical Efficacy of a Combination of Thymopentin and Antituberculosis Drugs in Treating Drug-Resistant Pulmonary Tuberculosis: Meta Analysis. Ther Clin Risk Manag. marzo de 2022;Volume 18:287-98. DOI: https://doi.org/10.2147/TCRM.S351317
Wagnew F, Alene KA, Kelly M, Gray D. The effect of undernutrition on sputum culture conversion and treatment outcomes among people with multidrug-resistant tuberculosis: A systematic review and meta-analysis. Int J Infect Dis. diciembre de 2022;S120197122200635X. DOI: https://doi.org/10.1016/j.ijid.2022.11.043
Caminero JA, Cayla JA, García-García JM, GarcíaPérez FJ, Palacios JJ, Ruiz-Manzano J. Diagnóstico y tratamiento de la tuberculosis con resistencia a fármacos. Arch Bronconeumol. septiembre de 2017;53(9):501-9. DOI: https://doi.org/10.1016/j.arbres.2017.02.006
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Lorena Soledad Heredia, Marcelo Adrián Estrin (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
